Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kyle Schweser

Orthopaedic Trauma Columbia, MO Medical Doctor

NPI 1912293952 CMS profile 5344898

1 Hospital Dr, Columbia, MO 65212

Open in the dashboard

General payments

$61,032

104 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$69,183 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Kyle Schweser of Columbia, MO is reported in the CMS Open Payments database as having received $61,032 across 104 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $69,183 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,092 27
2024 General $24,589 27
2023 General $10,806 16
2022 General $74 1
2021 General $4,263 16
2020 General $1,011 3
2019 General $4,199 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kyle Schweser
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Kyle Schweser were reported at $16,092. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Kyle Schweser Orthopaedic Trauma median Middle half National median
2019 $4,199 $1,475 $264–$6,401 $163
2020 $1,011 $596 $120–$4,020 $114
2021 $4,263 $919 $171–$4,697 $132
2022 $74 $1,547 $272–$7,240 $149
2023 $10,806 $1,330 $247–$5,875 $160
2024 $24,589 $1,288 $277–$6,797 $164
2025 $16,092 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $32,587 21 payments
  2. Arthrex, Inc. $18,235 21 payments
  3. Elite Orthopedics, LLC $6,003 17 payments
  4. KCI USA, Inc $1,200 2 payments
  5. DePuy Synthes Sales Inc. $856 14 payments
  6. Carbofix Orthopedics Inc $326 6 payments
  7. Stryker Corporation $300 5 payments
  8. Synthes GmbH $250 1 payment
  9. Zimmer Biomet Holdings, Inc. $227 2 payments
  10. Treace Medical Concepts, Inc. $181 3 payments
  11. Other $868 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $35,242 13 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,000 3 payments
  3. Travel and Lodging $7,178 22 payments
  4. Education $4,690 3 payments
  5. Food and Beverage $3,672 62 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $250 1 payment
Products named General payments · program years 2019–2025
  1. CONDUIT $1,885 6 payments
  2. PREVENA $1,200 2 payments
  3. FIBERGRAFT BG Morsels $559 2 payments
  4. FIBERGRAFT Aeridyan Matrix $334 3 payments
  5. BME NITINOL CONTINUOUS COMPRESSION IMPLANTS $252 5 payments
  6. INBONE $227 4 payments
  7. Lapiplasty System $181 3 payments
  8. Vivigen MIS Delivery System Spine Trauma $150 1 payment
  9. VIVIGEN MIS DELIVERY SYSTEM Spine $150 1 payment
  10. A.L.P.S. $136 1 payment
  11. Other $1,592 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

78

Median for Orthopedic Surgery: 203

Drug cost

$305

Median for Orthopedic Surgery: $1,433

Branded share of claims

26.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 21 $119
Meloxicam Generic 45 $108
Oxycodone Hcl Generic 12 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$88,360

Medicare's payments for the services billed

Medicare patients

130

Average age 70

Services billed

286

71 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Depression 44%
Diabetes 36%
Chronic kidney disease 35%
COPD 30%
Heart failure 28%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

104 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record